Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the ...
Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly ...
BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
Despite significant advances in addiction science, a persistent and critical challenge remains: the vast chasm between the ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Verantos, the global leader in high-validity real-world evidence at scale, announced today that it will present practical approaches for generating high-validity ...
This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback